What is NDC 0338-0221?

0338-0221 is the product NDC for Plasma-Lyte A, Sodium chloride 526 mg/100mL + 4 more ingredients injection, solution, listed with the FDA by Baxter Healthcare Corporation. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Plasma-Lyte A (Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride).

What is the active ingredient?

Sodium chloride, Sodium gluconate, Sodium acetate, Potassium chloride, Magnesium chloride.

Baxter Healthcare Corporation, NDC labeler code 0338. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Plasma-Lyte A?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Plasma-Lyte A NDC 0338-0221 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0338-0221Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00338-0221Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0338-0221-03	00338022103	500 mL in 1 BAG (0338-0221-03)Marketed from Feb 2, 1979
0338-0221-04	00338022104	1000 mL in 1 BAG (0338-0221-04)Marketed from Feb 2, 1979

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Plasma-Lyte A
Generic name (nonproprietary): sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride
Active ingredients: Sodium chloride — 526 mg/100mLSodium gluconate — 502 mg/100mLSodium acetate — 368 mg/100mLPotassium chloride — 37 mg/100mLMagnesium chloride — 30 mg/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Baxter Healthcare CorporationNDC labeler code 0338
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 017378
Marketing start: Feb 2, 1979
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 0338-0221_b7f70780-8da4-45bd-9aa4-78c88a2953d3SPL ID b7f70780-8da4-45bd-9aa4-78c88a2953d3SPL set ID 6ec9e61c-2c26-402f-8604-f446b2e34058RxCUI 801109, 801112UNII 451W47IQ8X, R6Q3791S76, 4550K0SC9B, 660YQ98I10, 02F3473H9O
Pharmacologic class: Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400338022103 followed by a unit qualifier and the quantity

Package 00338-0221-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 5, 2019.

Indications (excerpt from the label)

INDICATIONS AND USAGE PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) is indicated as a source of water and electrolytes or as an alkalinizing agent.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0338-0221

What is NDC 0338-0221?: 0338-0221 is the product NDC for Plasma-Lyte A, Sodium chloride 526 mg/100mL + 4 more ingredients injection, solution, listed with the FDA by Baxter Healthcare Corporation. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Plasma-Lyte A (Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride).
What is the active ingredient?: Sodium chloride, Sodium gluconate, Sodium acetate, Potassium chloride, Magnesium chloride.
Who is the labeler?: Baxter Healthcare Corporation, NDC labeler code 0338. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Plasma-Lyte A?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.